Your browser doesn't support javascript.
loading
Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls.
Mert, Ali; Vahaboglu, Haluk; Arslan, Ferhat; Batirel, Ayse; Saraçoglu, Kemal Tolga; Bastug, Aliye; Çagatay, Atahan; Irmak, Ilim; Dizman, Gülçin Telli; Ertenli, Ihsan; Altunal, Lütfiye Nilsun; Sengel, Buket Ertürk; Bayram, Mehmet; Omma, Ahmet; Amikishiyev, Shirkhan; Aypak, Adalet; Bes, Cemal; Bolukçu, Sibel; Içten, Sacit; Topeli, Arzu; Bektas, Murat; Arslan, Birsen Yigit; Öztürk, Sinan; Çomoglu, Senol; Aydin, Selda; Küçüksahin, Orhan; Içaçan, Ozan Cemal; Ince, Burak; Aghamuradov, Sarvan; Mutlu, Melek Yalçin; Simsek, Funda; Emre, Salih; Ustun, Cemal; Ergen, Pinar; Aydin, Özlem; Koç, Meliha Meriç; Sevindik, Ömür Gökmen; Odabasi, Zekaver; Korten, Volkan; Bodur, Hurrem; Güner, Rahmet; Ünal, Serhat; Kocak, Mehmet; Gül, Ahmet.
Afiliação
  • Mert A; Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey.
  • Vahaboglu H; Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.
  • Arslan F; Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.
  • Batirel A; Health Sciences University Hamidiye International Medical School, Kartal Dr. Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey.
  • Saraçoglu KT; Health Sciences University Hamidiye International Medical School, Kartal Dr. Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey.
  • Bastug A; Health Science University Turkey, Ankara City Hospital, 06800, Ankara, Turkey.
  • Çagatay A; Istanbul Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Istanbul University, Fatih, 34093, Istanbul, Turkey.
  • Irmak I; Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  • Dizman GT; Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  • Ertenli I; Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  • Altunal LN; Health Science University Turkey, Umraniye Training and Research Hospital, Istanbul, Turkey.
  • Sengel BE; Faculty of Medicine, Marmara University, Istanbul, Turkey.
  • Bayram M; Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey.
  • Omma A; Health Science University Turkey, Ankara City Hospital, 06800, Ankara, Turkey.
  • Amikishiyev S; Istanbul Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Istanbul University, Fatih, 34093, Istanbul, Turkey.
  • Aypak A; Health Science University Turkey, Ankara City Hospital, 06800, Ankara, Turkey.
  • Bes C; Health Science University Turkey, Bakirköy Sadi Konuk Education and Training Hospital, Istanbul, Turkey.
  • Bolukçu S; Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
  • Içten S; Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.
  • Topeli A; Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  • Bektas M; Istanbul Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Istanbul University, Fatih, 34093, Istanbul, Turkey.
  • Arslan BY; Health Science University Turkey, Umraniye Training and Research Hospital, Istanbul, Turkey.
  • Öztürk S; Health Science University Turkey, Umraniye Training and Research Hospital, Istanbul, Turkey.
  • Çomoglu S; Health Science University Turkey, Umraniye Training and Research Hospital, Istanbul, Turkey.
  • Aydin S; Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey.
  • Küçüksahin O; Yildirim Bayazit University, Ankara City Hospital, 06800, Ankara, Turkey.
  • Içaçan OC; Health Science University Turkey, Bakirköy Sadi Konuk Education and Training Hospital, Istanbul, Turkey.
  • Ince B; Istanbul Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Istanbul University, Fatih, 34093, Istanbul, Turkey.
  • Aghamuradov S; Istanbul Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Istanbul University, Fatih, 34093, Istanbul, Turkey.
  • Mutlu MY; Health Science University Turkey, Bakirköy Sadi Konuk Education and Training Hospital, Istanbul, Turkey.
  • Simsek F; Health Science University Turkey, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey.
  • Emre S; Health Science University Turkey, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey.
  • Ustun C; Acibadem Bakirkoy Hospital, Istanbul, Turkey.
  • Ergen P; Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.
  • Aydin Ö; Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.
  • Koç MM; Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
  • Sevindik ÖG; Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey.
  • Odabasi Z; Faculty of Medicine, Marmara University, Istanbul, Turkey.
  • Korten V; Faculty of Medicine, Marmara University, Istanbul, Turkey.
  • Bodur H; Health Science University Turkey, Ankara City Hospital, 06800, Ankara, Turkey.
  • Güner R; Yildirim Bayazit University, Ankara City Hospital, 06800, Ankara, Turkey.
  • Ünal S; Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  • Kocak M; Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey.
  • Gül A; Istanbul Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Istanbul University, Fatih, 34093, Istanbul, Turkey. agul@istanbul.edu.tr.
Rheumatol Int ; 42(3): 457-467, 2022 03.
Article em En | MEDLINE | ID: mdl-34515808
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Anticorpos Monoclonais Humanizados / Tratamento Farmacológico da COVID-19 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Rheumatol Int Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Turquia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Anticorpos Monoclonais Humanizados / Tratamento Farmacológico da COVID-19 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Rheumatol Int Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Turquia